Clinical correlates of depressive symptoms in familial Parkinson's disease

Movement Disorders

Volumn 23, Issue 15, 2008, Pages 2216-2223

  Pankratz, Nathan ^a   Marder, Karen S ^b   Halter, Cheryl A ^a   Rudolph, Alice ^c   Shults, Cliff W ^d,e   Nichols, William C ^f,g   Foroud, Tatiana ^a  

^a INDIANA UNIVERSITY   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^f CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^g UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Activities of daily living; Association; Depression; Hoehn and Yahr stage; Parkinson's disease

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; FAMILIAL DISEASE; FEMALE; FUNCTIONAL ASSESSMENT; FUNCTIONAL DISEASE; GERIATRIC DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DETERIORATION; MINI MENTAL STATE EXAMINATION; MOTOR DYSFUNCTION; PARKINSON DISEASE; PREDICTION; PRIORITY JOURNAL; UNIFIED PARKINSON DISEASE RATING SCALE;

ADULT; AGED; AGED, 80 AND OVER; APOLIPOPROTEINS E; DEPRESSION; DNA MUTATIONAL ANALYSIS; FAMILY HEALTH; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MUTATION; PARKINSON DISEASE; PROTEIN-SERINE-THREONINE KINASES; RNA-BINDING PROTEINS; SEVERITY OF ILLNESS INDEX;

EID: 61449133324     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22285     Document Type: Article

References (42)

1. de Rijk MC, Tzourio C, Breteler MM, et al. Prevalence of parkinsonism and Parkinson's disease in Europe: the europarkinson collaborative study. European community concerted action on the epidemiology of Parkinson's disease. J Neurol Neurosurg Psychiatry 1997;62:10-15.
2. Parkinson J. An essay on the shaking palsy. 1817. J Neuropsychiatry Clin Neurosci 2002;14:223-236.
3. Dooneief G, Mirabello E, Bell K, Marder K, Stern Y, Mayeux R. An estimate of the incidence of depression in idiopathic Parkinson's disease. Arch Neurol 1992;49:305-307.
4. Starkstein SE, Mayberg HS, Leiguarda R, Preziosi TJ, Robinson RG. A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1992;55:377-382.
5. Tandberg E, Larsen JP, Aarsland D, Cummings JL. The occurrence of depression in Parkinson's disease. A community-based study. Arch Neurol 1996;53:175-179.
6. Rojo A, Aguilar M, Garolera MT, Cubo E, Navas I, Quintana S. Depression in Parkinson's disease: clinical correlates and outcome. Parkinsonism Relat Disord 2003;10:23-28.
7. Leentjens AF. Depression in Parkinson's disease: conceptual issues and clinical challenges. J Geriatr Psychiatry Neurol 2004; 17:120-126.
8. Huber SJ, Paulson GW, Shuttleworth EC. Relationship of motor symptoms, intellectual impairment, and depression in Parkinson's disease. J Neurol Neurosurg Psychiatry 1988;51:855-858.
9. Tandberg E, Larsen JP, Aarsland D, Laake K, Cummings JL. Risk factors for depression in Parkinson disease. Arch Neurol 1997;54:625-630.
10. Lieberman A. Are dementia and depression in Parkinson's disease related? J Neurol Sci 2006;248:138-142.
11. Starkstein SE, Preziosi TJ, Berthier ML, Bolduc PL, Mayberg HS, Robinson RG. Depression and cognitive impairment in Parkinson's disease. Brain 1989;112 (Part 5):1141-1153.
12. Cole SA, Woodard JL, Juncos JL, Kogos JL, Youngstrom EA, Watts RL. Depression and disability in Parkinson's disease. J Neuropsychiatry Clin Neurosci 1996;8:20-25.
13. Giladi N, Treves TA, Paleacu D, et al. Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease. J Neural Transm 2000;107:59-71.
14. Liu CY, Wang SJ, Fuh JL, Lin CH, Yang YY, Liu HC. The correlation of depression with functional activity in Parkinson's disease. J Neurol 1997;244:493-498.
15. Cubo E, Bernard B, Leurgans S, Raman R. Cognitive and motor function in patients with Parkinson's disease with and without depression. Clin Neuropharmacol 2000;23:331-334.
16. Holroyd S, Currie LJ, Wooten GF. Depression is associated with impairment of ADL, not motor function in Parkinson disease. Neurology 2005;64:2134-2135.
17. Kuhn W, Heye N, Muller T, et al. The motor performance test series in Parkinson's disease is influenced by depression. J Neural Transm 1996;103:349-354.
18. Kostic VS, Djuricic BM, Covickovic-Sternic N, Bumbasirevic L, Nikolic M, Mrsulja BB. Depression and Parkinson's disease: possible role of serotonergic mechanisms. J Neurol 1987;234:94-96.
19. Iwasaki Y, Ikeda K, Igarashi O, Baba S. Depression is associated with impairment of ADL, not motor function in Parkinson's disease. Neurology 2006;66:956.
20. Jankovic J, McDermott M, Carter J, et al. Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson study group. Neurology 1990;40:1529-1534.
21. Jankovic J, Kapadia AS. Functional decline in Parkinson disease. Arch Neurol 2001;58:1611-1615.
22. Fahn S, Elton RL, UPDRS Development Committee. Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Goldstein M, editors. Recent developments in Parkinson's disease. Florham Park, NY: Macmillan Healthcare Information; 1987. p 153-163.
23. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
24. Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1982;17:37-49.
25. Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 1968; 114:797-811.
26. Pankratz N, Nichols WC, Uniacke SK, et al. Genome screen to identify susceptibility genes for Parkinson disease in a sample without parkin mutations. Am J Hum Genet 2002;71:124-135.
27. Marder K, Tang MX, Cote L, Stern Y, Mayeux R. The frequency and associated risk factors for dementia in patients with Parkinson's disease. Arch Neurol 1995;52:695-701.
28. Uhlmann RF, Larson EB. Effect of education on the mini-mental state examination as a screening test for dementia. J Am Geriatr Soc 1991;39:876-880.
29. Pankratz N, Byder L, Halter C, et al. Presence of an APOE4 allele results in significantly earlier onset of Parkinson's disease and a higher risk with dementia. Mov Disord 2006;21:45-49.
30. Nichols WC, Pankratz N, Hernandez D, et al. Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease. Lancet 2005;365:410-412.
31. Pankratz N, Pauciulo MW, Elsaesser VE, et al. Mutations in LRRK2 other than G2019S are rare in a north American-based sample of familial Parkinson's disease. Mov Disord 2006;21: 2257-2260.
32. Nichols WC, Elsaesser VE, Pankratz N, et al. LRRK2 mutation analysis in Parkinson disease families with evidence of linkage to PARK8. Neurology 2007;69:1737-1744.
33. Nichols WC, Pankratz N, Uniacke SK, et al. Linkage stratification and mutation analysis at the Parkin locus identifies mutation positive Parkinson's disease families. J Med Genet 2002;39:489-492.
34. Foroud T, Uniacke SK, Liu L, et al. Heterozygosity for a mutation in the parkin gene leads to later onset Parkinson disease. Neurology 2003;60:796-801.
35. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured clinical interview for DSM-IV Axis-I disorders administration booklet. Washington, D.C.: American Psychiatric Press; 1997.
36. Ertan FS, Ertan T, Kiziltan G, Uygucgil H. Reliability and validity of the geriatric depression scale in depression in Parkinson's disease. J Neurol Neurosurg Psychiatry 2005;76:1445-1447.
37. McDonald WM, Holtzheimer PE, Haber M, Vitek JL, McWhorter K, Delong M. Validity of the 30-item geriatric depression scale in patients with Parkinson's disease. Mov Disord 2006;21:1618-1622.
38. Mondolo F, Jahanshahi M, Grana A, Biasutti E, Cacciatori E, Di Benedetto P. The validity of the hospital anxiety and depression scale and the geriatric depression scale in Parkinson's disease. Behav Neurol 2006;17:109-115.
39. Louis ED, Tang MX, Cote L, Alfaro B, Mejia H, Marder K. Progression of parkinsonian signs in Parkinson's disease. Arch Neurol 1999;56:334-337.
40. Ramachandran G, Marder K, Tang M, et al. A preliminary study of apolipoprotein E genotype and psychiatric manifestations of Alzheimer's disease. Neurology 1996;47:256-259.
41. Pritchard AL, Harris J, Pritchard CW, et al. The effect of the apolipoprotein E gene polymorphisms and haplotypes on behavioural and psychological symptoms in probable Alzheimer's disease. J Neurol Neurosurg Psychiatry 2007;78:123-126.
42. Marsh L, Hirsch E, Williams JR, et al. Screening for depressive disorders in Parkinson's disease. In: American association of geriatric psychiatry annual meeting 2006, San Juan, PR, 2006.